Free Trial

3 Underperforming Nasdaq 100 Stocks Worth a Closer Look

Key Points

  • The strategy of rotating to the Nasdaq’s biggest laggards is far from foolproof, but it makes good sense.
  • Despite being down more than 40% year-to-date, analysts still have faith in Enphase Energy.
  • Moderna’s mRNA pipeline includes 45 vaccine and therapeutic candidates.
  • The company also announced a partnership with IBM to explore the use of generative AI and quantum computing in mRNA science.
  • With a consensus price target that implies nearly 80% upside, Zscaler could be one of the Nasdaq-100’s biggest comeback stories of 2023-2024.
  • Five stocks we like better than Enphase Energy.

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should You Invest $1,000 in Enphase Energy Right Now?

Before you consider Enphase Energy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enphase Energy wasn't on the list.

While Enphase Energy currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Enphase Energy (ENPH)
4.5714 of 5 stars
$57.33-6.3%N/A77.47Hold$90.42
Moderna (MRNA)
4.5488 of 5 stars
$30.96-0.4%N/A-3.34Hold$60.63
Zscaler (ZS)
4.2403 of 5 stars
$196.23+2.2%N/A-784.92Moderate Buy$226.56
Verizon Communications (VZ)
4.78 of 5 stars
$43.12-0.4%6.29%10.41Moderate Buy$46.08
Intel (INTC)
3.9713 of 5 stars
$23.74+2.8%2.11%-5.42Reduce$26.88
PDD (PDD)
4.8503 of 5 stars
$113.69-4.2%N/A11.10Moderate Buy$173.40
T-Mobile US (TMUS)
4.6494 of 5 stars
$269.69+2.1%1.31%27.89Moderate Buy$251.79
Activision Blizzard (ATVI)
0.7011 of 5 stars
$94.42flat1.05%34.59N/AN/A
Meta Platforms (META)
3.6975 of 5 stars
$668.20+1.5%0.31%27.93Moderate Buy$719.26
Tesla (TSLA)
4.2306 of 5 stars
$293.33+4.0%N/A143.79Hold$318.77
Align Technology (ALGN)
4.7106 of 5 stars
$187.03+0.7%N/A33.34Moderate Buy$269.91
Merck & Co., Inc. (MRK)
5 of 5 stars
$92.23+1.8%3.51%13.70Moderate Buy$116.39
International Business Machines (IBM)
4.4954 of 5 stars
$252.63-0.2%2.64%39.41Hold$231.44
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

Congress Cashes In on Stocks—Here’s How You Can Too!
5 Stocks to BUY NOW in March 2025
Archer Aviation: Sinking Now, Soaring Soon?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines